PATIENT FAQ’s

PATIENT FAQ’s

lung3

IS EARLY LUNG CANCER DETECTION SOMETHING NEW?

Early detection of lung cancer has the potential to save many thousands of lives each year.  However, only recently have new methods and technologies become available to make screening possible.  Older approaches, such as chest X-rays, have been shown to be of limited use.  New diagnostic technologies and improvements in advanced imaging (using CT scans) are helping make early detection a reality.  For the first time, physicians have effective  tools to identify lung cancer without dramatically burdening their patients with costly, unnecessary workups.

WHY HAVEN’T I HEARD ABOUT THIS TEST BEFORE?

PAULA’s Test was introduced in 2012 after many years of development.  Offered in a limited area for the first two years, PAULA’s Test is becoming commonly used in physician’s offices in Maryland, DC, Virginia, West Virginia and Pennsylvania. It is also now available in South Carolina, North Carolina, Tennessee, Kentucky, Florida, Texas, and New Jersey, through collaborating laboratories. Even though use of the test is growing quickly, some offices may not yet be set up to use this test.   Speak with your doctor about the test and share the information, found here.  Download a Brochure Discuss whether this test is appropriate for you.  If the doctor has any questions we will be happy to talk to him or her.

What is PAULA’s Test?

PAULA’s Test is a blood test that measures the levels of several cancer biomarkers in the blood. Through the Genesys Biolabs patent pending process, a “PAULA’s Test Score” is generated which indicates an increased risk of having lung cancer the day of the test.

Who are the candidates for this test?

  • Smokers and ex-smokers (20 years of smoking one pack of cigarettes per day or more)
  • 50+ years of age
  • No symptoms of lung cancer
  • Not currently undergoing yearly CT scans for lung cancer

*Patients with a previous diagnosed cancer may have an elevated score despite the current absence of cancer.

Is PAULA’s Test reimbursed by Insurance?

Genesys Biolabs works with most insurance companies, insurance plans and Medicare.  We file the claim on behalf of the patient, and we accept assignment from the insurance payers.  Because insurance plans vary by insurance company, state and employer, it is not possible to give exact costs for your remaining responsibility after the claim has been processed.   Patients may end up being responsible for some of the test cost, for example deductibles and copay.  Individual payment plans are available for those that cannot afford to pay or do not have health insurance.

How are PAULA’s Test results reported? Test results are faxed to the ordering physician’s office in 7-10 business days.

Should non-smokers take this test?

We cannot say.  PAULA’s Test has been developed and validated using samples from patients that fit the selection criteria of age and smoking history.   We do not have data to support using this test on persons that do not meet those criteria.

WHY IS IT CALLED “PAULA’s TEST”?

“PAULA” is an acronym for “Protein Assay Using Lung cancer Analytes”.  The test was named in memory of Paula Shore, the wife of Dr. Ron Shore, who succumbed to lung cancer in 2005.  Paula Shore was a smoker early in her life but had quit smoking 20 years before she was diagnosed with lung cancer.

* American Cancer Society. Cancer Facts & Figures 2011. Atlanta: American Cancer Society; 2011